asm tu series #6: david quinn - pembrolizumab in bladder cancer
Published 6 years ago • 54 plays • Length 16:08Download video MP4
Download video MP3
Similar videos
-
13:16
brief overview of anzup cancer trials group - ian davis
-
0:56
#anzup23 asm - introducing cap member michael twycross
-
0:57
anzup how is a clincial trial developed and funded?
-
1:00
adjuvant pembrolizumab in kidney cancer from keynote 564
-
4:09
surgeon! dr han is fired for mistreating shaun | the good doctor
-
59:24
rebuilding what we've lost in covid: a perspective from the icu
-
57:58
ion channels and cancer part 1
-
31:32
atlas and cdk4/6 inhibitor trials presented by dr. john smith ii, compass oncology
-
0:47
ian davis discusses clinical trials
-
0:48
ian davis - below the belt pedalthon
-
0:31
anzup community forum 13 july 2014 hear from the experts
-
9:52
talking urology with andrew weickhardt and betsy plimack
-
0:49
ian davis discusses anzup
-
0:52
ian davis - anzup multidisciplinary approach
-
7:54
asco: adjuvant chemotherapy plus novel therapies for muscle-invasive bladder cancer
-
7:40
david i. quinn, md: circulating tumor cells and prostate cancer from asco 2011
-
6:20
david i. quinn, md: testicular cancer update at asco 2013
-
7:05
combining the novel anti-cd47 antibody magrolimab with azacitidine in patients with tp53-mutant aml
-
1:05
dr. jean hoffman-censits on the results of a phase ii trial studying atezolizumab in bladder cancer
-
1:10
dr. jean hoffman-censits on the future of atezolizumab in bladder cancer